|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net loss | |||||
| Adjustments required to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Share-based compensation | |||||
| Loss from sale and disposal of fixed assets | |||||
| Gain on the sale of the MST Franchise | |||||
| Amortization of premium or discount on marketable securities | |||||
| Unrealized loss on cash equivalents | |||||
| Changes in operating assets and liabilities: | |||||
| Decrease in inventory | |||||
| Trade receivables, prepaid expenses and other assets and operating lease right of use assets | |||||
| Trade payables, accrued expenses, employee related obligations and other long-term liabilities | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash Flows From Investing Activities: | |||||
| Purchase of property and equipment | |||||
| Proceeds from the sale of the MST Franchise | |||||
| Proceeds from the sale and maturity of marketable securities | |||||
| Purchases of marketable securities | |||||
| Net cash provided by investing activities | |||||
| Proceeds related to the issuance of common shares and pre-funded warrants through private placement, net of issuance costs | |||||
| Proceeds related to the issuance of common shares through at-the-market offerings, net of issuance costs | |||||
| At-the-market Offering | |||||
| Redemption of convertible preferred stock | |||||
| Cash Flows From Financing Activities: | |||||
| Withholdings from exercise of options and issuance of shares for stock-based compensation arrangements, net | |||||
| Net cash used in financing activities | |||||
| Decrease in cash, cash equivalents and restricted cash | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the year | |||||
| Cash and cash equivalents at end of the year | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Supplementary information on investing and financing activities not involving cash flows: | |||||
| Accretion of preferred stock | |||||
| Issuance of vested shares under employee share purchase plan | |||||
| Cashless exercise of warrants | |||||
| Amount due from sale of MST Franchise | |||||
| Additions to operating lease right of use assets | |||||
| Additions to operating lease liabilities | |||||
| Interest received | |||||
Loading...